How Long Does Rejuran Healer Last? What Studies Show

There is no single verified duration for how long Rejuran Healer lasts. Published polynucleotide studies followed patients for roughly 12 weeks to 6 months, and clinics commonly describe a course of three to four sessions followed by maintenance. Actual longevity varies by skin condition, protocol and practitioner, so claims should be framed cautiously.

Key Takeaways

• Evidence for polynucleotide (PN) skin boosters is mostly short-term: follow-up in reviewed studies ranged from 12 weeks to 28 weeks.
• Typical studied protocols used 3 to 4 sessions spaced 2 to 4 weeks apart; clinic maintenance schedules differ and are not standardized.
• Reported side effects are mostly mild and transient, but the overall evidence quality is low to moderate.
• Distributors and clinics should avoid promising a fixed duration of results to patients.

How long does Rejuran Healer last?

No manufacturer-independent trial gives one fixed figure for Rejuran Healer. What the literature does show is a window of observed effect: a 2024 systematic review of nine polynucleotide studies (219 patients in total) used follow-up periods between 12 weeks and 28 weeks, and texture improvement was most visible at around 3 months. In one study included in that review, texture declined at 6 months but remained better than before treatment.

Many clinic websites quote maintenance every 6 to 12 months. Those figures are practice conventions, not outcomes from controlled long-term trials, and we recommend that B2B customers present them to patients only as general expectations that vary between individuals.

What do studies say about session numbers and intervals?

Studies of polynucleotide injections used anywhere from 2 to 12 treatments, most commonly 3 or 4 sessions at 2 to 4 week intervals. The table below summarizes a sample of protocols from the 2024 systematic review by Lampridou et al.

Because protocols, injection techniques and outcome measures differed, the review's authors could not pool the results in a meta-analysis. The 2024 practitioner-focused review in the same literature also notes that no study clearly specifies a standard number of sessions.

How does a PN skin booster work?

PN is believed to work through degradation by endogenous nucleases, followed by signaling and recycling of the resulting nucleotides. The 2025 paper by Marques et al. describes A2A receptor signaling on fibroblasts, linked to reduced pro-inflammatory cytokines, VEGF-related angiogenesis and collagen type I and III production, as well as a nucleotide salvage pathway.

The same paper proposes that longer PN chains degrade more slowly than short PDRN chains, which may support a longer stimulation window. Another review cautions that the mechanism of PN has not been directly demonstrated and is assumed to resemble PDRN. For a deeper comparison, see our article on PN vs PDRN differences.

What is the difference between PN and PDRN?

Under the Marques cutoff, PDRN covers polymers below 1,500 kDa, subdivided into low-molecular-weight (below 50 kDa) and medium-weight (50 to 1,500 kDa) fractions, while PN covers chains at or above 1,500 kDa. Product names and labels should be checked against this definition rather than assumed.

What factors influence how long results last?

Duration depends on factors that are hard to standardize, so practitioners should assess each patient individually. Commonly cited variables include the following:

• Baseline skin quality, age and sun exposure history.
• Number of sessions and the interval between them.
• Injection depth and technique, which differ across studies and clinics.
• Lifestyle factors and aftercare, including sun protection and barrier support products such as PDRN healing cream.
• Product selection: PN-only versus PN combined with hyaluronic acid, such as Rejuran HB, or periorbital formulations such as Rejuran I (Eye).

What side effects should practitioners expect?

Reported events are generally mild and transient. The systematic review lists pain, edema, itching, erythema, bruising and transient irritation, usually resolving within a week, and no severe adverse events. Edema was common in some studies, reported in 71.4% of participants in Kim 2022 and 50% in Jeong 2019.

These figures come from small studies, so they should not be read as complete safety profiles. Practitioners should screen patients, follow local regulations and product instructions, and keep records of any reactions.

How does Rejuran Healer compare with other skin boosters?

Rejuran Healer is a PN product, whereas other skin boosters rely on different mechanisms, such as hyaluronic acid hydration or ECM-based materials. Choice depends on the clinical goal and practitioner experience. See our comparison of Rejuran Healer vs exosome and our explainer on cross-linked vs non-cross-linked HA skin boosters.

What should clinics and distributors verify before stocking a PN skin booster?

Buyers should confirm authenticity, documentation and storage conditions before stocking any injectable skin booster. Because duration claims vary, the supply chain and the paperwork are what a business can actually control.

• Request manufacturer batch information and confirm packaging matches the official product presentation.
• Check the labelled storage instructions and ask the supplier how products are shipped and handled in transit.
• Confirm the regulatory status of the product in your own market with the local authority; approval should never be assumed from another country.
• Train staff to describe results as variable and to avoid guarantees in patient communication.
• Keep treatment records, including session dates and intervals, so the clinic builds its own outcome data over time.

Writing down your own protocol and outcomes is arguably the most useful response to the limited long-term evidence: it lets a clinic set expectations from its real patient population rather than from marketing figures.

Frequently Asked Questions

How many Rejuran Healer sessions are usually performed?

Published polynucleotide studies used between 2 and 12 treatments, most often 3 or 4 sessions at 2 to 4 week intervals. Clinic protocols vary, and no single standard has been established. The treating practitioner determines the number of sessions based on the patient's skin condition and goals.

Is Rejuran Healer the same as PDRN?

Not exactly. Under the 2025 Marques definition, PDRN refers to polymers below 1,500 kDa, while PN refers to longer chains at or above 1,500 kDa. Rejuran Healer is marketed as a PN product, so the two terms should not be treated as interchangeable in technical documentation.

When do patients typically see changes after polynucleotide treatment?

In the studies reviewed, texture improvements were most visible around 3 months, and some measures such as wrinkle depth were assessed at 8 to 18 weeks. Timing is gradual rather than immediate, and individual response varies with skin condition, protocol and practitioner technique.

What side effects are reported with polynucleotide injections?

Published studies mainly report mild, transient events: pain, edema, erythema, itching and bruising, usually resolving within about a week. No severe adverse events were reported in the systematic review, though the evidence base is small. Practitioners should still screen for contraindications and follow local regulations.

Can Rejuran Healer be combined with other treatments?

Combination protocols are common in practice, for example alongside botulinum toxin or fillers, but the evidence for specific combinations is limited. Sequencing and intervals should be decided by a qualified practitioner, and clinics should document their own protocols and outcomes.

Conclusion

The honest answer to how long Rejuran Healer lasts is that it depends: short-term evidence exists, long-term controlled data are limited, and maintenance timing is a clinical judgment. Clinics and distributors who set realistic expectations build more durable patient trust. To discuss sourcing, availability and documentation for authentic Korean PN skin boosters, send an inquiry to HolyPath.

References

• Lampridou S, et al. The Effectiveness of Polynucleotides in Esthetic Medicine: A Systematic Review (2024)
• Lee KWA, et al. Polynucleotides in Aesthetic Medicine: A Review of Current Practices and Perceived Effectiveness (2024)
• Marques C, et al. From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs) (2025)

This article is for informational purposes for licensed medical professionals and distributors. It is not medical advice. Treatments should be performed only by qualified practitioners in accordance with local regulations.